Genomics Market Size Worth $27.6 Billion By 2025 | CAGR: 9.7%

June 2018 | Report Format: Electronic (PDF)

The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period. Over the past few years, there have been significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in usage of genomic studies in clinical practices, which is reflected by growing trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making and thus, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools are motivating healthcare community to create precision-based therapies from surplus, available DNA data.

Advancements in genomics and associated technologies are significantly impacting crop genetics. Technological advancements in sequencing facilitate genomes & transcriptomes sequencing for several crops. Although a reference genome exists for several crops, resequencing and gene expression studies are required for in-depth study of key genes contributing to desired trait. Implementation of this information in crop breeding helps in development of advanced crops.

Companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. Through the collaboration, the latter was able to deploy former’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials. Such initiatives are aimed at increasing the adoption of genomic information in cancer management.

 To request a sample copy or view summary of this report, click the link below:

Further Key Findings From the Report Suggest:

  • High volume requirement and high cost of specific reagents contribute to substantial revenue growth. Companies are incorporating the trend of offering varied reagents that simplify workflow process

  • NGS-based services hold a major share in the genomics services segment due to their rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis

  • Biomarkers exhibit high clinical potential and efficiency across treatment of wide range of diseases. Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis

  • Growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive the market in the coming years.

  • As patients are focusing more on their health, direct-to-consumer (DTC) laboratory testing is increasingly gaining popularity. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process

  • Asia Pacific is the most promising region, exhibiting a CAGR of 12.7% during the forecast period. The growth of the region can be attributed to improving healthcare infrastructure

  • Some of the key players in the market are BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc., 23andMe, Inc.; Danaher; Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.

  • Market participants are engaged in making the technology available to users at a lower price and in a compact form.

Grand View Research has segmented the global genomics market on the basis of product & service, application & technology, end-use, and region:

Genomics Product and Service Outlook (Revenue, USD Million, 2014 - 2025)

  • Products

    • Instruments/Systems/Software

    • Consumables & Reagents

  • Services

    • Core Genomics Services

    • NGS-based Services

    • Biomarker Translation Services

    • Computational Services

    • Others

Genomics Application & Technology Outlook (Revenue, USD Million, 2014 - 2025)

  • Functional Genomics

    • Transfection

    • Real-time PCR

    • RNA interference

    • Mutational analysis

    • SNP analysis

    • Microarray analysis

  • Epigenetics

    • Bisulfite sequencing

    • Chromatin immunoprecipitation (ChIP & ChIP-Seq)

    • Methylated DNA immunoprecipitation (MeDIP)

    • High resolution melt (HRM)

    • Chromatin accessibility assays

    • Microarray analysis

  • Pathway Analysis

    • Bead-based analysis

    • Microarray analysis

    • Real-time PCR

    • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)

  • Biomarker Discovery

    • Mass spectrometry

    • Real-time PCR

    • Microarray analysis

    • Statistical analysis

    • Bioinformatics

    • DNA sequencing

  • Others

Genomics End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • Clinical Research

  • Academic and Government Institutes

  • Hospitals and Clinics

  • Pharmaceutical and Biotechnology Companies

  • Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • Middle East and Africa (MEA)

    • South Africa

Request Sample
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA